Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionSmartleaf Asset Management LLC
Latest Disclosed Ownership20,414 shares
Latest Disclosed Value $ 2,783,249
Smartleaf Asset Management LLC reports 18.10% increase in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Smartleaf Asset Management LLC filed a 13F-HR form disclosing ownership of 20,414 shares of Gilead Sciences, Inc. (CH:GILD) valued at $2,783,249 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 17,286 shares of Gilead Sciences, Inc.. This represents a change in shares of 18.10% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 20,414 3,128 18.10 2,783 30.72 0.1005
2026-02-13 2025-12-31 13F GILEAD SCIENCES COM 375558103 17,286 3,623 26.52 2,129 38.43 0.0807
2025-11-05 2025-09-30 13F GILEAD SCIENCES COM 375558103 13,663 4,937 56.58 1,539 59.38 0.0952
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 8,726 -2,093 -19.35 966 -20.18 0.0851
2025-05-14 2025-03-31 13F GILEAD SCIENCES COM 375558103 10,819 958 9.72 1,210 33.30 0.1167
2025-02-05 2024-12-31 13F GILEAD SCIENCES COM 375558103 9,861 3,572 56.80 907 72.76 0.0925
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 6,289 3,320 111.82 526 157.35 0.0638
2024-10-08 2024-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 2,969 495 20.01 204 13.33 0.0335
2024-08-13 2024-06-30 13F GILEAD SCIENCES COM 375558103 2,969 495 204 0.0335
2024-10-07 2024-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 2,474 1,614 187.67 181 168.66 0.0349
2024-05-03 2024-03-31 13F GILEAD SCIENCES COM 375558103 2,472 1,612 95 0.0229
2024-02-12 2023-12-31 13F GILEAD SCIENCES COM 375558103 860 860 68 0.0181
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.